Browsing: News

750px-flag_of_maryland-svgMichael Wheeler

After retiring from the league he joined the industry.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek. Download WeedWeek’s free 2016 election guide here.

Cannabis activist and former NFL-player Eugene Monroe is part of a company suing Maryland regulatorsfor rejecting its permit application. Maryland lawmaker Dr. Dan K. Morhain faces an ethics investigation. He championed MED and serves as the medical advisor to a MED company.
Colorado Springs Mayor and legalization opponent John Suthers (R) told an Arizona audience todecriminalize, don’t legalize. Colorado Springs ordered 9 consumption clubs to “ cease and desist” operations.
Lt. Gen. Jack L. Rives, Air Force judge advocate general, pins the Meritorious Service Medal on Col. Lindsey Graham in a Pentagon ceremony April 28, 2009. In addition to being a U.S. senator from South Carolina, Colonel Graham is an individual mobilization augmentee and the senior instructor at the Air Force JAG School at Maxwell Air Force Base, Ala. (U.S. Air Force photo)U.S. Air Force staff

Lt. Gen. Jack L. Rives, Air Force judge advocate general, pins the Meritorious Service Medal on Col. Lindsey Graham in a Pentagon ceremony April 28, 2009. In addition to being a U.S. senator from South Carolina, Colonel Graham is an individual mobilization augmentee and the senior instructor at the Air Force JAG School at Maxwell Air Force Base, Ala. (U.S. Air Force photo)

He held a hearing on how its classified by the Federal Government.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek. Download WeedWeek’s free 2016 election guide here.

South Carolina Sen. Lindsey Graham is the latest high-profile Republication to show hints of evolving on cannabis policy. He’s a cosponsor of the CARERS Act which would, Politico writes: “reclassify marijuana so that it is considered to have some medical value; permit banks to handle money from legal marijuana businesses; prevent the government from interfering with state-legal medical marijuana programs; exclude non-psychoactive marijuana extracts from the definition of marijuana; grant military veterans access to medical marijuana; and break the government’s monopoly on medical marijuana research.”

marijuana-court_medium%20flip.jpgadmin | Toke of the Town

Hundreds of cases may not go forward.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek. Download WeedWeek’s free 2016 election guide here.

An emerging evidence-tampering scandal in Boston-suburb Braintree has jeopardized hundreds of drug prosecutions. Former inmates explain drug dealing in prison to The Daily Beast.

Some states are reducing the size of drug-free school zones, a policy that’s under new scrutiny. The State University of New York, one of the country’s largest systems, will stop asking applicants if they have a felony conviction.

marijuana.money.nugget.thinkstock.565x300.jpgadmin | Toke of the Town

The new company will be a major player in seeds and pharmaceuticals, two cannabis sweet spots.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek. Download WeedWeek’s free 2016 election guide here.

In one of the largest mergers ever, the German chemical and pharamaceutical giant Bayer will buy seed company Monsanto for $66 billion. Mainstream reports did not bring it up, but both companies have long been seen as interested in the plant. (Bayer has a partnership with GW Pharmaceuticals.) In July, the far-left site Counterpunch published a piece called “ Monsanto, Bayer and the Push for Corporate Cannabis.”

Cannabis Reports CEO David Drake publicly shamed Leafly and Weedmaps for poor cybersecurity. Social network MassRoots and data firm Headset announced a strategic partnership.

At an L.A. conference, Viridian Capital Advisors president Scott Greiper said legalization will bring about the next industrial revolution.

Canna Law Blog discusses what makes for a weak brand mark? New cannabis business lawyer Daniel Shortt explains why he’s chosen the specialty.

 

Business school student Cameron Lehman writes about opening a dispensary with his plastic surgeon mom. U.C. Berkeley’s Haas business school is starting a speaker and case study series on the green rush.

Medical testing company Quest Diagnostics says the number of Americans testing positive for illegal drugs reached a decade high of 4%. Among “safety-sensitive” workers it was 1.8 %, a slight increase.

A new study found that states with legal, accessible MED saw decreases in opioid use in adults 21-40.

Reason asks “ What will control freaks ban next?” The answer appears to be the southeast Asian plant Kratom, which the DEA is adding to the list of schedule I drugs. Wired calls Kratom a promising treatmentfor opiate addition.

Dana-Farber Cancer Institute blogged on whether MED benefits cancer patients.

Food Safety News picked up a Leafly story about how to know if weed is past its sell-by date.

Camp Bud + Breakfast, a marijuana-friendly business in Colorado.Kate Simmons | Toke of the Town

Camp Bud + Breakfast, a marijuana-friendly business in Colorado.

Yes, tourists are coming to Colorado for the weed — but just not as many as you might think. In fact, according to a state-subsidized survey, only 12 percent of visitors to this state visit a dispensary.

Although tourism boosters shied away from discussing marijuana right after recreational use was legalized, pot was the focus of a panel yesterday morning at the Colorado Governor’s Tourism Conference in Beaver Creek. During “The Marijuana Message,” two experts spoke to an audience of about fifty tourism representatives from around the state about how many tourists are using cannabis, and how the state is working to educate them when they visit.

marijuana-england-uk.pngadmin | Toke of the Town

It received the British equivalent of bipartisan support. 

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek. Download WeedWeek’s free 2016 election guide here.

In the U.K., a group representing MPs and Peers from concluded that banning MED is “ irrational.” It is being touted as a major step towards legalization.

Cannabis is an issue in Berlin’s upcoming election.

Vermont’s legislature is revisiting REC after failing to pass it last year. Arkansas Gov. and former DEA chief Asa Hutchinson (R) criticized supporters of the state’s upcoming MED votes for misleading the public about the plant’s medical benefits.

BlueKudu founder and CEO Andrew Schrot (right) discusses a rebranding by his edibles company.Kate Simmons | Toke of the Town

BlueKudu founder and CEO Andrew Schrot (right) discusses a rebranding by his edibles company.

Denver Startup Week began in September 2012 as a chance for entrepreneurs to meet and trade ideas. Over the past five years, it’s evolved into an expansive event where anyone hoping to start a business can choose from hundreds of panel presentations featuring people who’ve been there, done that. And this year, ganjapreneurs are among the industry leaders sharing experiences and expertise.

At a September 13 panel titled “From Kitchen to ‘Shelf:’ Smart Growth Tips for Packaged Food Startups” at the Infinite Monkey Theorem Urban Winery, Andrew Schrot, founder and CEO of BlueKudu, a prominent edibles company, joined food-industry reps from 34 Degrees, Saso Pepper Co. and Capello’s Gluten Free; BrandJuice creative director John Bellina moderated a discussion that focused on the ever-growing food market in Colorado.

big-pharma1.jpegadmin | Toke of the Town

It currently sells a powerful opiate.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek

The Intercept reports that Insys Therapeutics, the company that donated $500,000 to oppose REC in Arizona, is about to release a synthetic THC spray to relieve side effects associated with chemotherapy that would compete directly with MED. It’s been more widely noted that Insys’ only current product is an opioid spray. Insys noted in a 2007 SEC filing that legalization is a threat to its business.

Forbes surveys a list of cannabis-involved pharmaceutical companies that are takeover targets. Insys is among them.

1 2 3 450